ClinicalTrials.gov
public full text
Public Domain
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
Ve-cadherin is expressed in endothelial cells. Systemic slerosis is a rare auto-immune disease with a endothelial dysfunction. This study is to evaluated the level of soluble VE-cadherin and VE-cadherin antibody in patients with systemic slerosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9#898521
- Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis.#1091239
- Metabolomic Analysis of Systemic Sclerosis#825876
- Proteomics and Genomics Combined With CT to Predict CVD#876161
- Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma#1152932
Record · ID 849674
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive